EZRA 10-K & 10-Q changes, risk factors and insider trading
Reliance Global Group, Inc. · Nasdaq · Insurance Agents, Brokers & Service · CIK 1812727 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “Our strategic expansion through EZRA International Group and the Scale51 investment model involves significant risks and uncertainties.”
New heading “Our investments in companies located in Israel expose us to risks related to geopolitical instability, armed conflict, and regional security conditions.”
New heading “If we fail to satisfy Nasdaq’s continued listing requirements, including the requirement to maintain a minimum market value of listed securities of $5 million, our common stock may be delisted, which could adversely affect the liquidity and market price of our securities.”
Removed heading “Worsening of Current U.S. economic conditions as a result of the COVID-19 pandemic and the Russian Federation Military Action may adversely affect our business.”
Largest changes
“If we fail to satisfy Nasdaq’s continued listing requirements, including the requirement to maintain a minimum market value of listed securities of $5 million, our common stock may be delisted, which could adversely affect the liquidity and market price of our securities.”see in full comparison
“We have entered into a revolving credit facility with an entity beneficially owned by our Chief Executive Officer, which creates conflicts of interest and may adversely affect our liquidity and financial condition. We are party to a revolving credit facility with YES Americana Group, LLC, an entity beneficially owned by our Chief Executive Officer, pursuant to which Americana has agreed to provide up to $2.0 million of unsecured financing to us. …”see in full comparison
“Military conflicts, acts of terrorism, cyberattacks, or other hostilities involving Israel or the broader Middle East region could disrupt the operations of companies located in Israel or otherwise adversely affect their business activities. Such events could result in damage to infrastructure, interruption of business operations, workforce disruptions due to military mobilization, delays in research and development activities, supply chain interruptions, restrictions on travel or transportation, or limitations on access to capital markets.”see in full comparison
“Worsening of Current U.S. economic conditions as a result of the COVID-19 pandemic and the Russian Federation Military Action may adversely affect our business.”see in full comparison
“If economic conditions were to worsen, a number of negative effects on our business could result, including declines in values of insurable exposure units, declines in insurance premium rates, the financial insolvency of insurance companies, the reduced ability of customers to pay, declines in the stock of residential housing or declines in property values. Also, if general economic conditions are poor, some of our customers may cease operations completely or be acquired by other companies, which could have an adverse effect on our results of operations and financial condition. …”see in full comparison
“If our common stock were to be delisted from Nasdaq, trading of our common stock could be conducted in the over-the-counter market, including on the OTC Markets or other quotation systems. Trading in the over-the-counter market is generally characterized by decreased trading volume, greater price volatility, and reduced liquidity compared to trading on a national securities exchange. As a result, an investor may find it more difficult to dispose of, or obtain accurate quotations for, our securities.”see in full comparison
Full comparison: every changed paragraph (46)
Our quarterly and annual financial results have fluctuated in the past and may continue to fluctuate significantly in the future due to a variety of factors, many of which are outside of our control. These fluctuations may make it difficult to evaluate our operating performance and may cause our results of operations in a particular period to fall below the expectations of investors or securities analysts. Factors that could cause fluctuations in our financial results include, among others:
● our limited operating history in certain aspects of our business and the evolving nature of our strategic initiatives, including our expansion through EZRA International Group and the Scale51 investment model;
● our ability to identify, negotiate, finance, and complete acquisitions or strategic investments, including majority ownership investments in technology-driven businesses, on acceptable terms or at all;
● the timing, structure, and success of acquisitions, investments, or other strategic transactions, including milestone-based investments that may occur over multiple periods;
● our ability to integrate acquired businesses or investments successfully and realize anticipated strategic or financial benefits;
● our ability to obtain additional financing, if required, to complete acquisitions, fund strategic investments, or support the operations and growth of existing and target businesses;
● the performance of companies in which we hold minority or controlling ownership interests, including the timing of their operational, commercialization, or technological development milestones;
● the availability of suitable acquisition or investment opportunities and competition for such opportunities;
● volatility in capital markets and the availability and cost of capital;
● our inability to retain or attract qualified employees, including key executives and management personnel;
● cybersecurity incidents or other interruptions to our information technology systems, data security infrastructure, or outsourced technology services;
● rapid technological changes that may require additional investment in technology, product development, or operational capabilities;
● changes in data privacy, cybersecurity, and other regulatory requirements applicable to our operations or those of companies in which we invest;
● economic conditions, inflation, interest rate changes, and other macroeconomic factors that may impact customer demand, acquisition activity, or capital availability;
● geographic concentration of our insurance operations in certain states, including Michigan, New York, Montana, New Jersey, Ohio, and Illinois;
● our ability to comply with financial and operational covenants contained in financing or other contractual arrangements;
● restrictions contained in certain agreements that may limit the discretion of our management in operating our business or pursuing strategic opportunities;
● the inherent uncertainties involved in estimates, judgments, and assumptions used in the preparation of financial statements in accordance with U.S. GAAP; and
● the improper disclosure of confidential or proprietary information.
Fluctuations
in our quarterly and annual financial results have resulted and will continue to result from numerous factors, including:
These
factors, some of which are not within our control, may cause the price of our common stock to fluctuate substantially. If our operating
results fail to meet or exceed the expectations of securities analysts or investors, our stock price could drop suddenly and significantly.
Due to the Company’s limited operating history, we believe period to period comparisons of our financial results are not always
meaningful and should not be relied upon as an indication of future performance.
Our strategic expansion through EZRA International Group and the Scale51 investment model involves significant risks and uncertainties.
In January 2026, we launched EZRA International Group and introduced the Scale51 investment model as part of our strategy to pursue majority ownership interests in selected technology-driven businesses. Under this model, we may seek to acquire controlling ownership positions, often through milestone-based or staged investments over time. This strategy exposes us to a number of risks that differ from those associated with our traditional insurance brokerage and InsurTech operations.
Technology companies, particularly early-stage or growth-stage businesses, often face substantial operational, technological, regulatory, and commercialization risks. Many such companies may have limited operating histories, unproven technologies, or uncertain paths to revenue generation or profitability. As a result, investments in these businesses may not achieve the anticipated strategic, operational, or financial benefits.
In addition, our Scale51 strategy may involve acquiring ownership interests through milestone-based investments that occur over multiple periods. These structures may require us to commit capital over time while the underlying business is still developing, and the anticipated milestones may not be achieved within expected timeframes or at all. If these milestones are not achieved, or if the underlying businesses do not perform as expected, our investment returns and strategic objectives could be adversely affected.
Our ability to successfully execute this strategy will depend on a number of factors, including our ability to identify suitable investment opportunities, conduct effective due diligence, negotiate favorable transaction terms, integrate acquired businesses, and support the growth and operations of the companies in which we invest. We may also be required to commit additional capital to support the operations, development, or commercialization activities of these companies, and such capital may not be available on acceptable terms or at all.
If our Scale51 strategy is not successfully implemented, or if the companies in which we invest fail to perform as anticipated, our business, financial condition, results of operations, and prospects could be materially adversely affected.
Our investments in companies located in Israel expose us to risks related to geopolitical instability, armed conflict, and regional security conditions.
As part of our strategic initiatives, including the Scale51 investment model implemented through EZRA International Group, we may invest in or acquire ownership interests in technology companies located in Israel. Israel has historically experienced periods of geopolitical instability, armed conflict, and security threats involving neighboring states and non-state actors. In recent years, tensions between Israel and Iran and their respective regional allies have escalated, including military operations, missile attacks, cyber operations, and other forms of conflict.
Military conflicts, acts of terrorism, cyberattacks, or other hostilities involving Israel or the broader Middle East region could disrupt the operations of companies located in Israel or otherwise adversely affect their business activities. Such events could result in damage to infrastructure, interruption of business operations, workforce disruptions due to military mobilization, delays in research and development activities, supply chain interruptions, restrictions on travel or transportation, or limitations on access to capital markets.
In addition, geopolitical instability may negatively impact economic conditions, investor sentiment, and capital availability in Israel and the broader region. Companies operating in Israel may experience increased operating costs, reduced access to financing, regulatory changes, or other operational challenges during periods of conflict or heightened security conditions.
To the extent that we invest in or acquire companies located in Israel, our business, financial condition, results of operations, and prospects could be materially adversely affected by geopolitical developments, armed conflict, or other security-related disruptions in the region.
To
date, much of our capital for acquiring and operating insurance agencies comes from loans from unaffiliated lenders, from direct
market market
capital raises or funds provided by an affiliate. We may be required to seek additional financing. We cannot
assure you that
such financing would be available on acceptable terms, if at all. If additional financing proves to be unavailable, we
would be
compelled to restructure or existing business,business and/or abandon a proposed acquisition or acquisitions. In addition, if we consummate
additional acquisitions, we may require additional financing to complement the operations or growth of that business. The failure to
secure additional financing could have a material adverse effect on the continued development or growth of our business.
A
significant portion of our insurance business is concentrated in Michigan, New York, Montana, New Jersey, Ohio, and Illinois. For the
years ended December 31, 2024, and 2023 we derived $14,054,361 and $13,731,826 respectively or 100% of our annual revenue, respectively, from
our operations located in these regions (FYE 2024 - Michigan – 53%, New York – 2%, Montana – 13% and Ohio –
16%, and Illinois – 17%. FYE 2023 - Michigan – 55%, New York – 2%, Montana – 14% and Ohio – 16%, and Illinois
– 13%). The insurance business is primarily a state-regulated industry, and therefore, state legislatures may enact laws that adversely
adversely affect the insurance industry. Because our business is concentrated in these four states, we face greater exposure to unfavorable changes
changes in regulatory conditions in those states than insurance intermediaries whose operations are more diversified through a greater number
number of states. In addition, the occurrence of adverse economic conditions, natural or other disasters, or other circumstances specific to
to or otherwise significantly impacting these states could adversely affect our financial condition, results of operations and cash flows.
We are susceptible to losses and interruptions caused by hurricanes or other weather conditions, and other possible events such as terrorist
acts and other natural or man-made disasters. Our insurance coverage with respect to natural disasters is limited and is subject to deductibles
and coverage limits. Such coverage may not be adequate or may not continue to be available at commercially reasonable rates and terms.
Worsening
of Current U.S. economic conditions as a result of the COVID-19 pandemic and the Russian Federation Military Action may adversely affect
our business.
Management
continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that
the virus could have a negative effect on the Company’s financial position or results of its operations, the specific impact is
not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
In
February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action,
various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further,
the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements
and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as
of the date of these financial statements.
If
economic conditions were to worsen, a number of negative effects on our business could result, including declines in values of insurable
exposure units, declines in insurance premium rates, the financial insolvency of insurance companies, the reduced ability of customers
to pay, declines in the stock of residential housing or declines in property values. Also, if general economic conditions are poor, some
of our customers may cease operations completely or be acquired by other companies, which could have an adverse effect on our results
of operations and financial condition. If these customers are affected by poor economic conditions, but yet remain in existence, they
may face liquidity problems or other financial difficulties that could result in delays or defaults in payments owed to us, which could
have a significant adverse impact on our consolidated financial condition and results of operations. Any of these effects could decrease
our net revenues and profitability.
If we fail to satisfy Nasdaq’s continued listing requirements, including the requirement to maintain a minimum market value of listed securities of $5 million, our common stock may be delisted, which could adversely affect the liquidity and market price of our securities.
Our common stock is currently listed on the Nasdaq Capital Market. Nasdaq imposes a number of continued listing requirements on issuers, including requirements relating to minimum stockholders’ equity, minimum bid price, public float, and the market value of listed securities. If we fail to satisfy any of these continued listing standards, Nasdaq may take steps to delist our common stock.
Nasdaq has established, and may from time to time modify, continued listing standards that include a requirement that a company maintain a minimum market value of listed securities of $5 million. If the market value of our listed securities were to fall below $5 million for a sustained period, we could be determined to be out of compliance with Nasdaq’s continued listing requirements. In such event, Nasdaq may provide us with notice of non-compliance and, depending on the circumstances and applicable rules, may initiate delisting proceedings.
If our common stock were to be delisted from Nasdaq, trading of our common stock could be conducted in the over-the-counter market, including on the OTC Markets or other quotation systems. Trading in the over-the-counter market is generally characterized by decreased trading volume, greater price volatility, and reduced liquidity compared to trading on a national securities exchange. As a result, an investor may find it more difficult to dispose of, or obtain accurate quotations for, our securities.
In addition, the delisting of our common stock from Nasdaq could materially adversely affect our ability to raise additional capital, could result in reduced analyst coverage and investor interest in our securities, and could negatively impact the perception of our company’s financial condition and prospects. Any of these factors could cause the market price of our common stock to decline and could materially and adversely affect our business, financial condition, and results of operations.
We have entered into a revolving credit facility with an entity beneficially owned by our Chief Executive Officer, which creates conflicts of interest and may adversely affect our liquidity and financial condition. We are party to a revolving credit facility with YES Americana Group, LLC, an entity beneficially owned by our Chief Executive Officer, pursuant to which Americana has agreed to provide up to $2.0 million of unsecured financing to us. Although the facility bears a below-market interest rate and provides flexibility for working capital and acquisition-related costs, it creates conflicts of interest because our Chief Executive Officer has an interest in the lender that may differ from the interests of our stockholders. The terms of this arrangement, including availability, maturity, and repayment provisions, may not reflect those that could have been obtained from an unaffiliated third party. In addition, amounts outstanding under the facility are payable upon maturity or earlier acceleration following an event of default, which could require us to use cash that otherwise would be available for operations or strategic initiatives. Any inability to repay or refinance amounts outstanding under this facility could adversely affect our liquidity, financial condition, and results of operations.
As
of December 31, 2024, there were no outstanding loan balances due to our CEO affiliated entities, Reliance Global
Holdings LLC and YES Americana Group, LLC (“Americana”). However, subsequent to December 31, 2024, and on March 5, 2025 (the “Americana Facility Effective Date”), the Company entered
into a revolving credit facility agreement (the “Americana Facility”), and issued a revolving note thereunder in favor of Americana, pursuant to which Americana agreed to lend the Company up to $600,000 for purposes of additional working capital for purposes of additional working capital related
to incremental Spetner acquisition related costs, and general uses. The Americana Facility carries interest at an annual rate of 0.1%,
calculated on a daily basis. Payment of principal and interest are due on the maturity date, 12 months from the Americana Facility Effective
Date and optional pre-payments are permitted at any time. As of March 6, 2025, there is $450,000 outstanding under the Americana Facility.
As
of December 31,02024,31, 2025, our Articles of Incorporation
authorized the issuance of 117,647,0592,000,000,000 shares of common stock, par value $0.086 per share. Effective February 7, 2025, our authorized
shares were increased to 2,000,000,000. As of December 31, 2024,2025, we had 2,250,21010,644,124 shares issued
and outstanding. We may be expected to
issue additional shares in connection with our pursuit of new business opportunities and new business
operations. To the extent that additional
shares of common stock are issued, our shareholders would experience dilution of their respective
ownership interests. If we issue shares
of common stock in connection with our intent to pursue new business opportunities, a change
in control of the Company may be expected
to occur. The issuance of additional shares of common stock may adversely affect the market
price of our common stock, in the event that
an active trading market commences.
Management's Discussion & Analysis (MD&A)
New heading “Strategic Investment Initiatives”
New heading “Digital Asset Treasury Strategy”
New heading “Portfolio Realignment and Debt Reduction”
New heading “Termination of Spetner Acquisition”
New heading “Capital Markets Activity”
New heading “Nasdaq Minimum Bid Price Notice”
Removed heading “Business Operations”
Removed heading “Business Trends and Uncertainties”
Removed heading “Financial Instruments”
Removed heading “Insurance Operations”
Removed heading “Insurance Acquisitions and Strategic Activities”
Removed heading “Private Placements”
Removed heading “Bylaws Amendment”
Removed heading “Increase in Authorized Shares”
Removed heading “Amendment No. 2 to Spetner Amended and Restated Stock Exchange Agreement”
Largest changes
“Amendment No. 2 to Spetner Amended and Restated Stock Exchange Agreement”see in full comparison
“On March 13, 2023, the Company entered into a securities purchase agreement with one institutional buyer for the purchase and sale of, (i) an aggregate of 9,120 shares (the “Common Shares”) of the Company’s common stock, par value $0.086 per share (the “Common Stock”) along with accompanying common warrants (the “Common Units”), (ii) prefunded warrants (the “Prefunded Warrants”) that are exercisable into 52,800 shares of Common Stock (the “Prefunded Warrant Shares”) along with accompanying common warrants (the “Pre-Funded Units”), and (iii) common warrants (the “Common Warrants”) to initially …”see in full comparison
“Further, the Amendment provides that the Additional Deposit Shares, (together with the Deposit Shares, as defined in and as issued pursuant to Amendment 1), shall be deemed a deposit and a prepayment of a portion of the First Purchase Price, and shall constitute a portion of the First Payment Shares, the value of the Deposit Shares and the Additional Deposit Shares, and the portion of the First Purchase Price to be paid by issuance of the First Payment Shares which has been satisfied by the issuance of the Deposit Shares and the Additional Deposit Shares, and collectively, was agreed to be …”see in full comparison
Net cash used in operating activities for the year ended December 31,see in full comparison20242025, was approximately$2,515,000,$3,095,000, compared to approximately $2,515,000$848,000for the year ended December 31,2023,2024, representing an increase of cash used in operations of$1,667,000,approximately $580,000, or197%.23%. The20242025 cash used comprises an approximate net loss of$9,072,000,$6,988,000 offset by non-cash positive adjustments of approximately $3,893,000.$6,507,000The non-cash adjustmentsstemmingstem from depreciation and amortization of approximately$1,786,000, asset impairments of $3,922,000,$1,332,000, amortization of debt issuance costs of approximately$40,000,$31,000, equity-based compensation for employees, directors, and service providers of approximately$858,000, change in estimated acquisitionearn-out payables of approximately $48,000,$5,708,000, non-cash lease expense of approximately$9,000 and off-set by the change in$4,000, fair valueof warrant liabilitychanges ofapproximatelydigital$156,000,assetsasofwell$17,000,asand changes in net working capital items in the net amount of approximately$50,000.$16,000, offset by a non-cash gain on the sales of businesses of approximately $3,183,000.
Full comparison: every changed paragraph (60)
Reliance Global Group, Inc. operates as a holding company that acquires, owns, and actively manages insurance distribution and technology-oriented businesses. Historically, the Company’s primary operations have consisted of the ownership and operation of wholesale and retail insurance agencies and related InsurTech platforms, including RELI Exchange and 5MinuteInsure.com.
During 2025, the Company undertook a series of portfolio and capital structure initiatives, including the sale of certain insurance brokerage assets, repayment of a significant portion of its outstanding indebtedness, and access to additional equity capital through committed facilities and public offerings. These actions were intended to streamline operations, strengthen the balance sheet, and support future growth initiatives.
In January 2026, the Company launched EZRA International Group and introduced its Scale51 structured acquisition model, under which the Company may pursue majority ownership positions in technology-driven businesses. The Company intends to continue operating its insurance platform as its foundational cash flow base while selectively evaluating expansion opportunities consistent with its holding company framework.
The following discussion and analysis should be read in conjunction with the Company’s consolidated financial statements and related notes included elsewhere in this Annual Report.
Reliance Global Group, Inc.
was incorporated in Florida on August 2, 2013 under the name Ethos Media Network, Inc. In September 2018, Reliance Holdings, purchased
a controlling interest in the Company. Ethos Media Network, Inc. was renamed Reliance Global Group, Inc. on October 18, 2018.
We
operate as a diversified company engaging in business in the insurance market, as well as other related sectors. Our focus is to grow
the Company by pursuing an aggressive acquisition strategy, initially and primarily focused upon wholesale and retail insurance agencies.
We are led and advised by a management team that offers over 100 years of combined business expertise in real estate, insurance, and
the financial service industry.
In
the insurance sector, our management has extensive experience acquiring and managing insurance portfolios in several states, as well
as developing specialized programs targeting niche markets. Our primary strategy is to identify specific risk to reward arbitrage opportunities
and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale
and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset
value appreciation while generating interim cash flows.
As
part of our growth and acquisition strategy, we continue to survey the current insurance market for value-add acquisition opportunities.
As of December 31, 2024, we have acquired nine insurance agencies and long term, we seek to conduct all transactions and acquisitions
through our direct operations.
Over
the next 12 months, we plan to focus on the expansion and growth of our business through continued asset acquisitions in insurance markets
and organic growth of our current insurance operations through geographic expansion and market share growth.
Further,
we launched our 5MinuteInsure.com (“5MI”) Insurtech platform during 2021 which expanded our national footprint. 5MI is a
high-tech proprietary tool developed by us as a business to consumer portal which enables consumers to instantly compare quotes from
multiple carriers and purchase their car and home insurance in a time efficient and effective manner. 5MI taps into the growing number
of online shoppers and utilizes advanced artificial intelligence and data mining techniques, to provide competitive insurance quotes
in around 5 minutes with minimal data input needed from the consumer. The platform launched during the summer of 2021 and currently operates
in 46 states offering coverage with more than 30 highly rated insurance carriers.
With
the acquisition of Barra, we launched RELI Exchange, our business-to-business (B2B) InsurTech platform and agency partner network that
builds on the artificial intelligence and data mining backbone of 5MinuteInsure.com. Through RELI Exchange we on-board agency partners
and provide them an InsurTech platform white labeled, designed and branded specifically for their business. This combines the best of
digital and human capabilities by providing our agency partners and their customers quotes from multiple carriers within minutes. Since
its inception, RELI Exchange, has increased its agent roster by close to 300%.
Business
Operations
We’ve
adopted a ‘One-Firm’ strategy, whereby the Reliance owned and operated agencies come together to operate as one cohesive
unit which allows for efficient and effective cross-selling, cross-collaboration, and the effective deployment of the Company’s
human capital. This strategy also aims to enhance the Company’s overall market presence across the U.S., with all business lines
operating under the RELI Exchange brand. It’s expected to benefit agents and clients by improving relationships with carriers,
leading to better commission and bonus contracts due to higher business volumes. The approach also strengthens the capability of RELI
Exchange agency partners in securing diverse insurance policies and fosters increased cross-selling opportunities. This unified strategy
positions the company for rapid scaling and integration of accretive acquisitions, expanding its industry reach.
Business
Trends and Uncertainties
The
insurance intermediary business is highly competitive, and we actively compete with numerous firms for customers, properties and insurance
companies, many of which have relationships with insurance companies, or have a significant presence in niche insurance markets that
may give them an advantage over us. Other competitive concerns may include the quality of our products and services, our pricing and
the ability of some of our customers to self-insure and the entrance of technology companies into the insurance intermediary business.
A number of insurance companies are engaged in the direct sale of insurance, primarily to individuals, and do not pay commissions to
agents and brokers.
Financial
Instruments
The
Company’s financial instruments as of December 31, 2024, consist of derivative warrants. These are accounted at fair value as of
inception/issuance date, and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating,
(non-cash) gain or loss.
Insurance
Operations
Our
insurance operations focus on the acquisition and management of insurance agencies throughout the U.S. Our primary focus is to pinpoint
undervalued wholesale and retail insurance agencies with operations in growing or underserved segments (including healthcare and Medicare,
as well as personal and commercial insurance lines). We then focus on expanding their operations on a national platform and improving
operational efficiencies in order to achieve asset value appreciation while generating interim cash flows. In the insurance sector, our
management team has over 100 years of experience acquiring and managing insurance portfolios in several states, as well as developing
specialized programs targeting niche markets. We plan to accomplish these objectives by acquiring wholesale and retail insurance agencies
it deems to represent a good buying opportunity (as opposed to insurance carriers) as insurance agencies bear no insurance risk. Once
acquired, we plan to develop them on a national platform to increase revenues and profits through a synergetic structure. The Company
is initially focused on segments that are underserved or growing, including healthcare and Medicare, as well as personal and commercial
insurance lines.
Revenues
The
Company’s revenue is primarily comprised of commission paid by health insurance carriers related to insurance plans that have been
purchased by a member who used the Company’s service. The Company defines a member as an individual currently covered by an insurance
plan, including individual and family, Medicare-related, small business, and ancillary plans, for which the Company is entitled to receive
compensation from an insurance carrier.
Insurance
Acquisitions and Strategic Activities
As
of the date of this filing, we have acquired nine insurance agencies (see table below). As we continue to execute on our acquisition
strategy, our reach within the insurance industry can provide us with the ability to offer lower rates, which could boost our competitive
position within the industry.
Strategic Investment Initiatives
In January 2026, the Company launched EZRA International Group and introduced its Scale51 operating model, under which the Company intends to pursue majority ownership positions in technology-driven businesses while continuing to operate its insurance brokerage and InsurTech platforms as its operational base.
On February 23, 2026, the Company completed the initial closing of its investment in Enquantum Ltd., a cybersecurity company developing post-quantum encryption and next-generation data protection technologies, acquiring approximately 8% of Enquantum’s issued and outstanding share capital on a fully diluted basis. The Share Purchase Agreement provides for additional milestone-based tranche investments that, if completed, would increase the Company’s ownership to 51%. Future funding of these milestone tranches will require additional capital deployment by the Company. The timing and magnitude of such future investments remain subject to milestone achievement or waiver and the Company’s capital allocation decisions. The Company continues to evaluate additional potential investments consistent with its holding company strategy; however, there can be no assurance that any additional transactions will be completed.
Digital Asset Treasury Strategy
In September 2025, the Company adopted a digital asset treasury strategy pursuant to which it may allocate a portion of its treasury assets to cryptocurrencies and related blockchain initiatives. As of December 31, 2025, the Company held digital assets reflected on its consolidated balance sheet. Digital asset holdings are subject to market price volatility, which may impact future results of operations. The Company evaluates digital asset allocations alongside other capital deployment opportunities, including operating investments and strategic acquisitions.
Portfolio Realignment and Debt Reduction
During 2025, the Company completed the sale of certain insurance brokerage assets, including the Fortman Insurance Services business and the Employee Benefits Solutions (“EBS”) and US Benefits Alliance (“USBA”) businesses. Aggregate proceeds from these transactions were used in part to reduce outstanding indebtedness. In July 2025, the Company repaid approximately $5.0 million of its Oak Street long-term debt and subsequently made an additional repayment following the EBS and USBA asset sale. These actions reduced the Company’s leverage and ongoing interest expense entering 2026.
Termination of Spetner Acquisition
In July 2025, the previously announced Stock Exchange Agreement relating to the proposed acquisition of Spetner Associates, Inc. was terminated. In connection with the termination, the Company expensed previously issued non-refundable equity prepayments associated with the contemplated transaction. The Company has no ongoing obligations under the terminated agreement.
Capital Markets Activity
In August 2025, the Company entered into an At-the-Market (“ATM”) Sales Agreement under which it may offer and sell shares of its common stock from time to time pursuant to an effective shelf registration statement, subject to regulatory limitations and market conditions. During the year ended December 31, 2025, the Company generated approximately $2.2 million in net proceeds from sales under the ATM program.
Also in August 2025, the Company entered into a Common Stock Purchase Agreement with White Lion Capital, LLC providing access to up to $10.0 million of capital through an equity line of credit facility, subject to specified limitations and conditions. As of December 31, 2025, capacity remained available under the facility.
Subsequent to year-end, on January 29, 2026, the Company completed a public offering generating gross proceeds of approximately $2.0 million before offering expenses. The Company intends to use the net proceeds for working capital, strategic initiatives, and general corporate purposes.
Nasdaq Minimum Bid Price Notice
On December 12, 2025, the Company received a notification from The Nasdaq Stock Market indicating that the closing bid price of its common stock had been below the minimum $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) for 30 consecutive business days. The notice has no immediate effect on the listing of the Company’s common stock. The Company has 180 calendar days to regain compliance. If at any time during this period the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance. If the Company does not regain compliance within the initial 180-day period, but meets the continued listing requirement for market value of publicly held shares and all other applicable initial listing standards for The Nasdaq Capital Market (other than the minimum bid price requirement), and provides written notice of its intention to cure the deficiency during a second compliance period, including, if necessary, by effecting a reverse stock split, the Company may be eligible for an additional 180 calendar day compliance period. There can be no assurance that the Company will regain compliance within the applicable compliance period.
Private
Placements
On
March 13, 2023, the Company entered into a securities purchase agreement with one institutional buyer for the purchase and sale of, (i)
an aggregate of 9,120 shares (the “Common Shares”) of the Company’s common stock, par value $0.086 per share (the “Common
Stock”) along with accompanying common warrants (the “Common Units”), (ii) prefunded warrants (the “Prefunded
Warrants”) that are exercisable into 52,800 shares of Common Stock (the “Prefunded Warrant Shares”) along with accompanying
common warrants (the “Pre-Funded Units”), and (iii) common warrants (the “Common Warrants”) to initially acquire
up to 123,839 shares of Common Stock (the “Common Warrant Shares”) (representing 200% of the Common Shares and Prefunded
Warrant Shares) in a private placement offering (the “Private Placement”). Additionally, the Company agreed to issue a warrant
to the Placement Agent (defined below), to initially acquire 3,096 shares of common stock (the “PA Warrant”). The closing
of the Private Placement occurred on March 16, 2023. As of December 31, 2024, with exception to the PA Warrant which remains outstanding, the aforementioned warrants
have been exercised into common shares and none remain outstanding.
Stock
Splits
On February 23, 2023, the Company effectuated a 1-for-15
reverse split of the Company’s issued and outstanding common stock (the “Reverse Split-2023”). The par value remained
unchanged.
On July 1, 2024, the Company effectuated a 1-for-17
reverse stock split of the Company’s issued and outstanding common stock (the “Reverse Split-2024”). The par value remained
unchanged. All amounts presented in this Annual Report on Form 10-K have been retrospectively adjusted to reflect the Reverse Split-2023
and the Reverse Split-2024 for all periods presented, unless otherwise indicated. The Reverse Split-2024 resulted in a rounding addition
of approximately 110,350 shares valued at par, totalling $9,490 for which shares were issued in July 2024.
Bylaws Amendment
On February
4, 2025, the Company’s Board of Directors approved Amendment No. 1 (the “Bylaws Amendment”) to the Company’s bylaws.
The Bylaws Amendment had the effect of (i) amending the title of the bylaws to be “Bylaws of Reliance Global Group, Inc.”,
to reflect the change of Company’s name since adoption of the bylaws (in May 2017, the Company’s name was changed from Eye
on Media Network, Inc. to Ethos Media Network, Inc., and in October 2018, the Company’s name was changed from Ethos Media Network,
Inc. to Reliance Global Group, Inc.); and (ii) reducing the quorum needed to hold a meeting of the Company’s stockholders from a
majority of the shares entitled to vote, represented in person or proxy, to thirty-three and one-third (33-1/3%) percent of the shares
entitled to vote, represented in person or proxy.
Increase in Authorized Shares
On February 7, 2025, the Company filed
articles of amendment (the “Articles Amendment”) to its articles of incorporation, as amended, with the Florida
Secretary of State. The Articles Amendment had the effect of increasing the total number of authorized shares of the Company’s
common stock from 117,647,058 to 2,000,000,000. The Articles Amendment had no effect on the number of authorized shares of preferred stock.
Accordingly, following the filing of the Articles Amendment, effective February 7, 2025, the Company’s authorized capital stock
consisted of 2,750,000,000 shares, representing (i) 2,000,000,000 shares of common stock, and (ii) 750,000,000 shares of preferred
stock.
The Articles Amendment was approved
by the Company’s Board of Directors on October 2, 2024, and by the Company’s stockholders on December 31, 2024.
Amendment No. 2 to Spetner
Amended and Restated Stock Exchange Agreement
On February 20, 2025, the
Company entered into an Amendment No. 2 (the “Amendment”) to that certain Amended and Restated Stock Exchange Agreement, dated
as of September 6, 2024 (the “Original Agreement”), by and among the Company, Spetner Associates, Inc. (“Spetner”),
Jonathan Spetner, and Agudath Israel of America (“Agudath”), as amended on October 29, 2024 (“Amendment 1”). Mr.
Spetner and Agudath may be referred to herein collectively as the “Sellers” and each individually as a “Seller”.
Pursuant to the Amendment,
the Company agreed to issue to each of Mr. Spetner and Agudath 78,500 shares of the Company’s common stock as a non-refundable deposit
and a prepayment of a portion of the First Purchase Price, in the amount of $239,425 (collectively the “Additional Deposit Shares”).
The Additional Deposit Shares were issued on February 20, 2025.
Further, the Amendment provides
that the Additional Deposit Shares, (together with the Deposit Shares, as defined in and as issued pursuant to Amendment 1), shall be
deemed a deposit and a prepayment of a portion of the First Purchase Price, and shall constitute a portion of the First Payment Shares,
the value of the Deposit Shares and the Additional Deposit Shares, and the portion of the First Purchase Price to be paid by issuance
of the First Payment Shares which has been satisfied by the issuance of the Deposit Shares and the Additional Deposit Shares, and collectively,
was agreed to be equal to $568,856. The Amendment also sets forth that the purchase price for the First Closing Shares shall be $16,050,000,
and that $6,500,000 of the First Purchase Price (the “Cash Payment”), shall be paid to Mr. Spetner.
The Original Agreement, prior
to Amendment 1, provided that the First Payment Shares would be issued solely to Mr. Spetner, however, the Amendment provides that, in
the event that the First Closing occurs, the issuance of Deposit Shares and the Additional Deposit Shares to Agudath as set forth above
shall be deemed to satisfy the obligations of the Company to issue such applicable portion of First Payment Shares to Mr. Spetner.
Further, the Amendment provides that, in the
event the First Closing occurs, the Deposit Shares and the Additional Deposit Shares shall be retained by the Sellers and shall constitute
payment of a portion of the First Payment Shares. The Deposit Shares and the Additional Deposit Shares shall be non-refundable to the
Company unless the First Closing is prevented by the Sellers.
As
of December 31, 2024,2025, the Company had a cash balance of approximately $2,731,000, of which approximately $1,416,000 was restricted, and working capital
of approximately $1,875,000, compared with a cash balance of approximately $1,798,000, of which approximately $1,425,000 was restricted, and
working capital of approximately $416,000, compared with a cash balance of approximately $2,739,000, of which approximately $1,410,000
was restricted and a working capital of approximately $1,189,000$416,000 as of December 31, 2023.2024.
Net
cash used in operating activities for the year ended December 31, 20242025, was approximately $2,515,000,$3,095,000, compared to approximately
$2,515,000 $848,000
for the year ended December 31, 2023,2024, representing an increase of cash used in operations of $1,667,000,approximately $580,000, or 197%.
23%. The 20242025 cash used comprises
an approximate net loss of $9,072,000,$6,988,000 offset by non-cash positive adjustments of approximately
$3,893,000. $6,507,000The non-cash adjustments stemmingstem from depreciation
and amortization of approximately $1,786,000, asset impairments of $3,922,000,$1,332,000, amortization of debt
issuance costs of approximately $40,000,
$31,000, equity-based compensation for employees, directors, and service providers of approximately $858,000, change in estimated acquisition
earn-out payables of approximately $48,000,$5,708,000, non-cash lease expense of approximately $9,000 and off-set by the change in$4,000, fair value of
warrant liabilitychanges of approximatelydigital $156,000,assets asof well$17,000, asand changes in net
working capital items in the net amount of approximately $50,000.$16,000, offset by a non-cash gain on the sales of businesses of
approximately $3,183,000.
Net
cash flows usedprovided inby investing activities for the year ended December 31, 2024,2025, was approximately $83,000,$5,328,000, compared to net cash
flows used
in investing activities of approximately $710,000$83,000 for the year ended December 31, 2023.2024. The 20242025 net cash used provided
comprises of cash spent
for the purchase of property, equipment, and intangible assets.assets of $43,000, net cash spent for the investment
of digital assets of approximately $126,000 offset by cash received in the sales of businesses of approximately
$5,497,000.
Net
cash providedused byin financing activities for the year ended December 31, 2024,2025, was approximately $1,657,000,$1,300,000, as compared to $967,000net cash
provided by financing activities of $1,657,000 for the year ended December 31, 2023.2024. The 20242025 net cash providedused primarily comprises
of cash proceeds from an ATM offering of
approximately $3,713,000,$2,161,000, from a private placement of shares and warrants of approximately $2,137,000, from common shares issued through an
equity line of credit of approximately $823,000, from a related party loan payable of approximately $1,146,000, and from short term financings
of $192,000, offset by repayments on debt principal repayments of approximately $1,397,000, payments$5,990,000, on
related party loans of
approximately $661,000 and cash provided by proceeds net of payments$1,188,000, on short term financings of approximately
$192,000 $3,000.and dividends paid of approximately $388,000.
Revenue recognition: The Company’s revenue is primarily comprised of commission paid by health insurance carriers related to insurance plans that have been purchased by a member who used the Company’s service. The Company defines a member as an individual currently covered by an insurance plan, including individual and family, Medicare-related, small business, and ancillary plans, for which the Company is entitled to receive compensation from an insurance carrier. All commission revenue is recorded net of any deductions for estimated commission adjustments due to lapses, policy cancellations, and revisions in coverage.
Revenue
recognition: All commission revenue is recorded net of any deductions for estimated commission adjustments due to lapses, policy
cancellations, and revisions in coverage.
What changed in the latest 10-Q
Risk Factors
Largest changes
“If our common stock were to be delisted from Nasdaq, trading of our common stock could be conducted in the over-the-counter market, including on the OTC Markets or other quotation systems. Trading in the over-the-counter market is generally characterized by decreased trading volume, greater price volatility, and reduced liquidity compared to trading on a national securities exchange. As a result, an investor may find it more difficult to dispose of, or obtain accurate quotations for, our common stock. …”see in full comparison
“Any delisting of our common stock from Nasdaq could materially and adversely affect the liquidity and market price of our common stock, reduce analyst coverage and institutional investor interest, impair our ability to access the capital markets, including under financing arrangements that require a Nasdaq listing (including under our existing at-the-market offering program which requires Nasdaq listing), and adversely affect our business, financial condition, and results of operations. …”see in full comparison
“Any perception that we may not comply with Nasdaq's continued listing requirements, the public announcement or receipt of any deficiency notice, or a delisting of our common stock by Nasdaq could adversely affect our ability to attract new investors, decrease the liquidity of the outstanding shares of our common stock, reduce the price at which such shares trade, and increase the transaction costs inherent in trading such shares. …”see in full comparison
“In addition to the Minimum Bid Price Requirement, Nasdaq's continued listing standards include requirements that we maintain a minimum stockholders' equity of $2.5 million (or alternatively a minimum market value of listed securities of $35 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the three most recently completed fiscal years), minimum public float, and corporate governance standards including with respect to the independence of our directors and the composition of our Board committees. …”see in full comparison
“If the Company does not regain compliance with the Minimum Bid Price Requirement during the Initial Compliance Period, the Company may be eligible for an additional 180-calendar-day compliance period, provided that the Company satisfies Nasdaq's continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (other than the Minimum Bid Price Requirement) and notifies Nasdaq of its intention to cure the deficiency, including, if necessary, by effecting a reverse stock split. …”see in full comparison
“On December 12, 2025, the Company received a deficiency notice (the “Bid Price Notice”) from the Listing Qualifications staff of Nasdaq notifying the Company that, for the prior 30 consecutive business days, the closing bid price for the Company's common stock had been below $1.00 per share, and that the Company was therefore not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Bid Price Notice does not result in the immediate delisting of the Company's common stock from Nasdaq. …”see in full comparison
Full comparison: every changed paragraph (12)
We
haveFailure receivedto asatisfy noticeNasdaq’s new minimum Market Value of non-complianceListed withSecurities
requirement, Nasdaq'sits minimum bid price requirement,requirement andor ourother failure to regain compliance with Nasdaq's
continued listing requirements could result in athe delisting of our common stock.
In July 2026, the SEC approved Nasdaq’s adoption of a new continued listing standard requiring companies listed on The Nasdaq Capital Market to maintain a minimum Market Value of Listed Securities (“MVLS”) of $5.0 million. Under the new rule, if a company’s MVLS remains below $5.0 million for 30 consecutive business days, Nasdaq may issue a Staff Delisting Determination without first providing a customary compliance period. Although a company may appeal such determination, its common stock would generally be suspended from trading on Nasdaq during the appeal process.
Based on the current market price of our common stock, our Market Value of Listed Securities has recently been below the $5.0 million threshold. Accordingly, there can be no assurance that we will satisfy the MVLS continued listing requirement within the applicable period prescribed by Nasdaq’s rules or otherwise maintain compliance with Nasdaq’s continued listing standards.
On December 12, 2025, the Company received a notice from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) that it was not in compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5550(a)(2). On June 2, 2026, Nasdaq notified the Company that it had regained compliance with the minimum bid price requirement and that the matter was closed. Nasdaq further noted that, pursuant to Listing Rule 5810(c)(3)(A)(iv), because of the Company’s prior reverse stock splits, the Company may not be eligible for a future compliance period under the minimum bid price rule if it were to become non-compliant with that requirement again.
Any delisting of our common stock from Nasdaq could materially and adversely affect the liquidity and market price of our common stock, reduce analyst coverage and institutional investor interest, impair our ability to access the capital markets, including under financing arrangements that require a Nasdaq listing (including under our existing at-the-market offering program which requires Nasdaq listing), and adversely affect our business, financial condition, and results of operations. If our common stock were delisted from Nasdaq, it would likely trade on an over-the-counter market, where trading is generally characterized by lower trading volumes, reduced liquidity, wider bid-ask spreads, and greater price volatility than trading on a national securities exchange.
Our
common stock is currently listed on The Nasdaq Capital Market. Nasdaq imposes a number of continued listing requirements on listed issuers,
including requirements relating to corporate governance, minimum bid price, public float, minimum stockholders' equity, and the market
value of listed securities.
On
December 12, 2025, the Company received a deficiency notice (the “Bid Price Notice”) from the Listing Qualifications staff
of Nasdaq notifying the Company that, for the prior 30 consecutive business days, the closing bid price for the Company's common stock
had been below $1.00 per share, and that the Company was therefore not in compliance with the minimum bid price requirement set forth
in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Bid Price Notice does not result in the immediate
delisting of the Company's common stock from Nasdaq. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided
an initial period of 180 calendar days, or until June 10, 2026 (the “Initial Compliance Period”), to regain compliance with
the Minimum Bid Price Requirement. To regain compliance, the closing bid price of the Company's common stock must be at least $1.00 per
share for a minimum of ten consecutive business days during the Initial Compliance Period.
If
the Company does not regain compliance with the Minimum Bid Price Requirement during the Initial Compliance Period, the Company may be
eligible for an additional 180-calendar-day compliance period, provided that the Company satisfies Nasdaq's continued listing requirement
for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market (other than the Minimum
Bid Price Requirement) and notifies Nasdaq of its intention to cure the deficiency, including, if necessary, by effecting a reverse stock
split. There can be no assurance that the Company will be eligible for, or that Nasdaq will grant, an additional compliance period. If
the Company is not granted an additional compliance period, or if it appears to Nasdaq that the Company will not be able to cure the
deficiency, Nasdaq will provide notice that the Company's common stock is subject to delisting, in which case the Company would have
the right to appeal Nasdaq's determination to a Nasdaq Hearings Panel.
On
May 7, 2026, the Board approved a reverse stock split of the Company's outstanding shares of common stock at a ratio of 1-for-40. The
Company intends to effect the reverse stock split with the principal objective of regaining compliance with the Minimum Bid Price Requirement
prior to the expiration of the Initial Compliance Period on June 10, 2026. There can be no assurance, however, that the reverse stock
split will achieve its intended effect of increasing the market price of our common stock to a level sufficient to satisfy the Minimum
Bid Price Requirement, that any such increase will be sustained for the required ten consecutive business days during the Initial Compliance
Period, or that the Company will otherwise regain or maintain compliance with the Minimum Bid Price Requirement or any other Nasdaq continued
listing requirement. Even if the reverse stock split causes the closing bid price of our common stock to exceed $1.00 per share initially,
the price may decline thereafter as a result of, among other factors, the dilutive effect of future financings, market reaction to the
reverse stock split, the trading volatility of small-capitalization companies, and broader market conditions, any of which could cause
us to fall back out of compliance with the Minimum Bid Price Requirement.
In
addition to the Minimum Bid Price Requirement, Nasdaq's continued listing standards include requirements that we maintain a minimum stockholders'
equity of $2.5 million (or alternatively a minimum market value of listed securities of $35 million or net income from continuing operations
of $500,000 in the most recently completed fiscal year or in two of the three most recently completed fiscal years), minimum public float,
and corporate governance standards including with respect to the independence of our directors and the composition of our Board committees.
Recent and contemplated changes to the composition of our Board of Directors, including the potential loss of independence of one or
more of our directors as a result of our acquisition activities, could affect our compliance with Nasdaq's corporate governance requirements,
including the requirement that our audit committee consist of at least three independent directors. We may not satisfy one or more of
these continued listing standards in the future, and any failure to do so could result in our receiving additional deficiency notices
from Nasdaq and, ultimately, the delisting of our common stock.
Any
perception that we may not comply with Nasdaq's continued listing requirements, the public announcement or receipt of any deficiency
notice, or a delisting of our common stock by Nasdaq could adversely affect our ability to attract new investors, decrease the liquidity
of the outstanding shares of our common stock, reduce the price at which such shares trade, and increase the transaction costs inherent
in trading such shares. A delisting could also deter broker-dealers from making a market in or otherwise seeking or generating interest
in our common stock, and might deter certain institutions and persons from investing in our common stock.
If
our common stock were to be delisted from Nasdaq, trading of our common stock could be conducted in the over-the-counter market, including
on the OTC Markets or other quotation systems. Trading in the over-the-counter market is generally characterized by decreased trading
volume, greater price volatility, and reduced liquidity compared to trading on a national securities exchange. As a result, an investor
may find it more difficult to dispose of, or obtain accurate quotations for, our common stock. A delisting of our common stock from Nasdaq
could also materially adversely affect our ability to raise additional capital (including under our existing at-the-market offering program
and our equity line of credit with White Lion Capital, LLC, which require Nasdaq listing), could trigger default or other adverse consequences
under our outstanding warrants or other agreements, could result in reduced analyst coverage and investor interest in our securities,
could subject our common stock to “penny stock” rules under the Exchange Act, and could negatively impact the perception
of our financial condition and prospects. Any of these factors could cause the market price of our common stock to decline and could
materially and adversely affect our business, financial condition, and results of operations.
Management's Discussion & Analysis (MD&A)
New heading “Equity Investments”
New heading “Reverse Stock Split”
New heading “Three Months Ended June 30, 2026”
New heading “Comparison of the six months ended June 30, 2026 to the six months ended June 30, 2025”
New heading “Six Months Ended June 30, 2026”
New heading “Commission Income (CI)”
New heading “Commission Expense (CE)”
New heading “Salaries and Wages (S&W)”
New heading “General and Administrative Expenses (G&A)”
New heading “Marketing and Advertising Expenses (M&A)”
New heading “Depreciation and Amortization (D&A)”
New heading “Other Income (Expense)”
New heading “Insurance segment comparison of the six months ended June 30, 2026 to the six months ended June 30, 2025”
Removed heading “Recent Developments”
Removed heading “Reverse Stock Split and Nasdaq Compliance”
Removed heading “Strategic Ventures Initiatives”
Removed heading “Strategic Ventures – Results of Operations”
Removed heading “Three Months Ended March 31, 2026”
Largest changes
“Insurance segment comparison of the six months ended June 30, 2026 to the six months ended June 30, 2025”see in full comparison
“Comparison of the six months ended June 30, 2026 to the six months ended June 30, 2025”see in full comparison
Full comparison: every changed paragraph (79)
Reliance Global Group, Inc. is an InsurTech company focused on acquiring, owning and operating wholesale and retail insurance agencies and developing technology solutions that enhance insurance distribution and operations. The Company’s primary operations consist of its insurance brokerage businesses and proprietary technology platforms, including RELI Exchange and 5MinuteInsure.com.
Equity Investments
During the first half of 2026, the Company, through its Scale 51 operating model, and EZRA International Group (“EIG”), pursued selected strategic equity investments in technology and healthcare-related businesses intended to complement its core insurance operations. During the second quarter of 2026, management reassessed its strategic priorities and capital allocation objectives and reduced its level of active strategic investment activity while continuing to support and monitor its existing investments and selectively evaluate future investment opportunities.
Enquantum
In the first quarter of 2026, the Company initiated an investment in Enquantum Ltd., a cybersecurity company focused on post-quantum encryption and data protection technologies, through a $166,000 secured convertible note. In February 2026, the Company entered into a Share Purchase Agreement pursuant to which it agreed, subject to specified milestones and other conditions, to acquire up to a 51% ownership interest in Enquantum for aggregate consideration of approximately $2.1 million, payable in tranches.
During February 2026, the Company completed the initial closing under the agreement and acquired an approximate 8% ownership interest on a fully diluted basis through the conversion of the note and a cash investment. Additional tranche-based investments through June 30, 2026 increased the Company’s ownership to approximately 20% on a fully diluted basis, or approximately 34% of Enquantum’s issued and outstanding shares. During the six months ended June 30, 2026, the Company funded an aggregate of approximately $0.8 million under the agreement.
Reliance
Global Group, Inc. operates as a holding company that acquires, owns, and actively manages insurance distribution and technology-oriented
businesses. Historically, the Company’s primary operations have consisted of the ownership and operation of wholesale and retail
insurance agencies and related InsurTech platforms, including RELI Exchange and 5MinuteInsure.com. In January 2026, as described below,
the Company launched EZRA International Group as a strategic platform intended to support the Company’s expansion through majority
investments in technology-focused businesses.
Recent
Developments
Formation of LGG and Investment in Innervate
In
April 2026, the Company formed LifeSci Global Group LLC (“LGG”) to pursue investments in healthcare-related companies, with
the Company holding a majority ownership interest of approximately 51%.51% through its wholly owned subsidiary EZRA International Group,
LLC (“EIG”). The remaining ownership interest is held by an entity affiliated
with certain members of the Company’s management
and Board of Directors. LGG is consolidated as a majority-owned subsidiary, and the interest not held by the Company is presented as
a noncontrolling interest. In connection with the formation, the CompanyEIG entered
into a financing arrangement with LGG providing for borrowings
of up to $2.0 million, of which $0.5 million had been advanced as of April
June 30, 2026.2026 (and $0.65 million had been advanced as of the date
of this report). Amounts advanced under this arrangement eliminate in consolidation.
Also
in April 2026, LGG entered into an agreement to invest up to approximately $2.0 million in Innervate Radiopharmaceuticals LLC,LLC (“Innervate”),
an early-stage
life sciences company, in exchange for a minority equity interest and certain additional rights, including warrants and
preferential payment rights. The investment is payable in installments at LGG’s discretion. Using proceeds from the LGG financing arrangement
described above, as of June 30, 2026, LGG had funded $0.5 million and as of the date of this report had funded $0.65 million, and held
a minority equity interest in Innervate, which is accounted for as an equity investment. The Company expects LGG to serve as
a platform
for expanding its presence in the healthcare and life sciences sector.
These
arrangements involve related parties, as certain members of management and the Board hold ownership interests in the minority member
of LGG, and one director isserves affiliatedas withthe chief executive officer of Innervate. The transactions were reviewed and approved by the independent
and disinterested members of the
Company’s Board of Directors.
Reverse
Stock Split and Nasdaq Compliance
On
May 7, 2026, our Board of Directors approved a 1-for-40 reverse stock split of our issued and outstanding common stock, as well as a
proportional reduction in the number of authorized shares of common stock. The reverse stock split will become effective for trading
purposes on May 19, 2026.
The
reverse stock split was undertaken to increase the market price of our common stock and to enable us to regain compliance with the $1.00
minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Following the effectiveness of the reverse stock split, we are required
to maintain a minimum closing bid price of at least $1.00 per share for a period of ten consecutive trading days to regain compliance,
with a compliance deadline of June 10, 2026.
As
a result of the reverse stock split, every 40 shares of our outstanding common stock would be automatically combined into one share of
common stock, and the number of authorized shares of common stock will be reduced proportionately. The reverse stock split did not affect
stockholders’ relative ownership interests, except with respect to the treatment of fractional shares.
While
the reverse stock split increased the per share trading price of our common stock, there can be no assurance that we will be able to
maintain compliance with the minimum bid price requirement for the required period or continue to meet Nasdaq’s continued listing
standards. We continue to monitor our stock price and may take additional actions, if necessary, to maintain compliance with applicable
listing requirements.
SubsequentDuring
the tosecond Marchquarter 31,of 2026, the Company alsodetermined determined
not to proceed with its previously disclosed proposed acquisition of an interest in
Scentech Medical Ltd. No definitive agreement was
executed, and the parties did not reach final terms. The Company has not incurred any
termination fees or other material liabilities in
connection with the discontinuation of those discussions.
On May 6, 2026, the Company’s stockholders approved
an amendment to the Company’s 2025 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance
thereunder by 14,000,000 shares, from 2,000,000 shares to 16,000,000 shares. The amendment was approved at the Company’s 2026 Annual
Meeting of Stockholders and is intended to support the Company’s ongoing employee, director, consultant, and strategic incentive
compensation programs.
Strategic
Ventures Initiatives
In
January 2026, the Company launched EZRA International Group and introduced its Scale51 operating model (“Scale51”), under
which the Company intends to pursue majority ownership positions in technology-driven businesses while continuing to operate its insurance
brokerage and InsurTech platforms as its operational base.
In
furtherance of this strategy, the Company initiated an investment in Enquantum Ltd., a cybersecurity company focused on post-quantum
encryption and data protection technologies, through a $166,000 secured convertible note. In February 2026, the Company entered into
a Share Purchase Agreement pursuant to which it agreed, subject to specified milestones and other conditions, to acquire up to a 51%
ownership interest in Enquantum for aggregate consideration of approximately $2.1 million, payable in tranches.
During
February 2026, the Company completed the initial closing under the agreement and acquired an approximate 8% ownership interest on a fully
diluted basis through the conversion of the note and a cash investment. Additional tranche-based investments during March and April 2026
increased the Company’s ownership to approximately 16% on a fully diluted basis.
In
February 2026, the Company amended its at-the-market (“ATM”) offering program, increasing the aggregate amount of common
stock that may be offered and sold from time to time to approximately $1.8 million. The ATM program provides the Company with
additional flexibility to access capital as needed, subject to market conditions. Additionally, beginning in the first quarter of
20262026, toand date,through the date of this report, the Company sold shares under its ATM program for combined net proceeds of approximately $214,000,
$1,284,000, with remaining
availability of approximately $1.6 million$456,000 under the program for future issuances.
On
January 22, 2026, the Company announced that its ticker symbol on the Nasdaq Capital Market will change from “RELI” to “EZRA,”
effectivewhich took effect at the open of trading on Monday, January 26, 2026. The Company’s common stock will remainremained listed on the Nasdaq Capital
Market and the Company’s CUSIP number will remainremained unchanged. No action iswas required by the Company’s stockholders in connection
with the ticker symbol change.
On May 6, 2026, the Company’s stockholders approved an amendment to the Company’s 2025 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 350,000 shares, from 50,000 shares to 400,000 shares. The amendment was approved at the Company’s 2026 Annual Meeting of Stockholders and is intended to support the Company’s ongoing employee, director, consultant, and strategic incentive compensation programs.
Reverse Stock Split
On May 7, 2026, our Board of Directors approved a 1-for-40 reverse stock split of our issued and outstanding common stock, as well as a proportional reduction in the number of authorized shares of common stock. The reverse stock split became effective for trading purposes on May 18, 2026.
The reverse stock split was undertaken to increase the market price of our common stock and to enable us to regain compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). On June 2, 2026, we received a letter from the Nasdaq Listing Qualifications Department notifying us that we had regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), and that the matter is now closed.
As a result of the reverse stock split, every 40 shares of our outstanding common stock were automatically combined into one share of common stock, and the number of authorized shares of common stock was reduced proportionately. The reverse stock split did not affect stockholders’ relative ownership interests, except with respect to the treatment of fractional shares. As a result of the reverse stock split, the CUSIP number assigned to the Company’s common stock was changed to 75946W504.
While the reverse stock split increased the per share trading price of our common stock, there can be no assurance that we will continue to meet Nasdaq’s continued listing standards in the future. We continue to monitor our stock price and may take additional actions, if necessary, to maintain compliance with applicable listing requirements.
As
of MarchJune 31,30, 2026, we have acquired multiple insurance brokeragesbrokerages, some of which were subsequently sold (see table below). As our acquisition strategy continues, our reach
within the insurance arena can provide us with the ability to offer lower rates, which could boost our competitive position within the
industry.
Comparison
of the three months ended MarchJune 31,30, 2026 to the three months ended MarchJune 31,30, 2025
Three Months Ended June 30, 2026
The
decrease in consolidated Commission Income was primarily drivenattributable byto portfolio realignments completed during 2025, including the sale
divestitures of Fortman
Insurance Services (FIS), Employee Benefits Solutions (EBS), and U.S. Benefits Alliance (USBA), which reduced eliminated
commission revenue
from previously generated by these operations. This decline was partially offset by approximately 11% organic growth in revenue from our retained
businesses.
The decrease in consolidated Commission Expense was primarily attributable to the Company’s portfolio realignment initiatives completed during 2025, including the divestitures of Fortman Insurance Services (FIS), Employee Benefits Solutions (EBS), and U.S. Benefits Alliance (USBA), which eliminated commission expense previously incurred by these operations.
The increase in consolidated Commission Expense was primarily attributable to higher commission rates driven by general
market conditions, as well as increased commission expense from the Company’s retained businesses consistent with approximately
11% year-over-year revenue growth. The businesses divested as part of the Company’s portfolio realignment initiatives historically
generated proportionally lower commission expense relative to the commission revenue they contributed.
The
decrease in consolidated Salaries and Wages was primarily attributable to lower non-cash share-based compensation expense, as well as
the elimination of compensation
costs associated with Fortman Insurance Services and Employee Benefits Solutions following their divestiture.divestiture
offset by increased compensation costs.
The
decline in consolidated General and Administrative expenses was primarily attributable was primarily attributable to lower non-cash equity compensation expense
for directors, as well as cost efficiencies and reduced operating expenses resulting from the Company’sCompany's OneFirm
operating initiative,
partiallymodel. offsetThe comparison was also affected by increasedScale51 Scale51-relatedinitiatives costs.in 2026 and acquisition activities in 2025.
The
decrease in consolidated total other
expense was primarily attributable to lower interest expense, including on related party balances,
driven by paydowns and the payoff
of certain loan balances, lower other expenses primarily related to charitable contributions, and a
realized gain on the sale on digital assets partially offset by a loss on an equity method investment, higher other expenses primarily related to charitable
contributions, and unrealized losses on digital assets due to fair value changes.investment.
AEBITDA
The decrease in consolidated AEBITDA was primarily attributable to significantly lower add-backs for non-cash equity-based compensation in 2026 compared to the prior-year period, partially offset by improved operating performance, including reductions in salaries and wages and general and administrative expenses.
Comparison of the six months ended June 30, 2026 to the six months ended June 30, 2025
Six Months Ended June 30, 2026
Commission Income (CI)
The decrease in consolidated Commission Income was primarily attributable to portfolio realignments completed during 2025, including the divestitures of Fortman Insurance Services (FIS), Employee Benefits Solutions (EBS), and U.S. Benefits Alliance (USBA), which eliminated commission revenue previously generated by these operations offset by an increase in commission income from our retained businesses.
Commission Expense (CE)
The decrease in consolidated Commission Expense was primarily attributable to the Company’s portfolio realignment initiatives completed during 2025, including the divestiture of Employee Benefits Solutions (EBS) which eliminated commission expense previously incurred by these operations, offset by higher commission rates of our retained businesses due to general market conditions.
Salaries and Wages (S&W)
The decrease in consolidated Salaries and Wages was primarily attributable to lower non-cash share-based compensation expense, as well as the elimination of compensation costs associated with Fortman Insurance Services and Employee Benefits Solutions following their divestiture offset by increased compensation costs.
General and Administrative Expenses (G&A)
The decline in consolidated General and Administrative expenses was primarily attributable to cost efficiencies and reduced operating expenses resulting from the Company's OneFirm operating model. The comparison was also affected by Scale51 initiatives in 2026 and acquisition activities in 2025.
Marketing and Advertising Expenses (M&A)
The increase in consolidated Marketing and Advertising expenses reflects the Company’s current marketing strategy and increased investment in growth initiatives.
Depreciation and Amortization (D&A)
The decrease in consolidated Depreciation and Amortization expense reflects the pursuant to the passage of time as assets become fully amortized and elimination of FIS, EBS, USBA assets.
Other Income (Expense)
The decrease in consolidated total other expense was primarily attributable to lower interest expense, including on related party balances, driven by paydowns and the payoff of certain loan balances, and a realized gain on the sale on digital assets partially offset by a loss on an equity method investment and higher other expenses primarily related to charitable contributions.
Insurance
segment comparison of the three months ended MarchJune 31,30, 2026 to the three months ended MarchJune 31,30, 2025
Insurance
segment revenue decreased compared to the prior-year period. Commission Income decreased, primarily drivenattributable byto portfolio realignments
completed during 2025, including the saledivestitures of Fortman Insurance Services (FIS), Employee Benefits Solutions (EBS), and U.S. Benefits
Alliance (USBA),
which reducedeliminated commission revenue frompreviously generated by these operations. This decline was partially offset by approximately 11% organic growth in revenue
from our retained businesses.
EZRA insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 4 filings (4 insiders, 1 trade date, 34,727 shares, about $124.2K). Net open-market shares: -34,727 (purchases minus sales); net value about -$124.2K.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Markovits Joel |
Open-market sale | 9,329 | $2.55 | $23.8K |
| 2026-08-03 | Blumenfrucht Alex |
Open-market sale | 8,830 | $3.97 | $35.1K |
| 2026-08-03 | Beyman Yaakov |
Open-market sale | 1,000 | $3.31 | $3.3K |
| 2026-08-03 | Beyman Yaakov |
Open-market sale | 8,120 | $3.90 | $31.7K |
| 2026-08-03 | Fruchtzweig Ben |
Open-market sale | 7,448 | $4.08 | $30.4K |
| 2026-07-30 | Markovits Joel |
Shares withheld for tax | 9,375 | $1.90 | $17.8K |
| 2026-07-30 | Korman Judah |
Shares withheld for tax | 7,315 | $1.90 | $13.9K |
| 2026-07-30 | Beyman Yaakov |
Shares withheld for tax | 8,302 | $1.90 | $15.8K |
| 2026-07-30 | Beyman Mordechai Menachem |
Shares withheld for tax | 2,455 | $1.90 | $4.7K |
| 2026-07-30 | Beyman Ezra |
Shares withheld for tax | 43,950 | $1.90 | $83.5K |
| 2026-07-30 | Fruchtzweig Ben |
Shares withheld for tax | 1,288 | $1.90 | $2.4K |
| 2026-07-20 | Markovits Joel |
Shares withheld for tax | 2,255 | $2.26 | $5.1K |
| 2026-07-20 | Korman Judah |
Shares withheld for tax | 1,772 | $2.26 | $4.0K |
| 2026-07-20 | Beyman Yaakov |
Shares withheld for tax | 2,212 | $2.26 | $5.0K |
| 2026-07-20 | Beyman Mordechai Menachem |
Shares withheld for tax | 595 | $2.26 | $1.3K |
| 2026-07-20 | Beyman Ezra |
Shares withheld for tax | 10,651 | $2.26 | $24.1K |
| 2026-07-20 | Fruchtzweig Ben |
Shares withheld for tax | 312 | $2.26 | $705 |
| 2026-07-06 | Markovits Joel |
Shares withheld for tax | 2,080 | $3.10 | $6.4K |
| 2026-07-06 | Korman Judah |
Shares withheld for tax | 1,634 | $3.10 | $5.1K |
| 2026-07-06 | Beyman Mordechai Menachem |
Shares withheld for tax | 547 | $3.10 | $1.7K |
| 2026-07-06 | Beyman Ezra |
Shares withheld for tax | 9,828 | $3.10 | $30.5K |
| 2026-07-06 | Fruchtzweig Ben |
Shares withheld for tax | 287 | $3.10 | $890 |
| 2026-06-24 | Markovits Joel |
Grant/award | 23,039 | — | — |
| 2026-06-24 | Korman Scott |
Grant/award | 7,168 | — | — |
| 2026-06-24 | Korman Judah |
Grant/award | 21,941 | — | — |
| 2026-06-24 | Brickman Sheldon |
Grant/award | 7,168 | — | — |
| 2026-06-24 | Blumenfrucht Alex |
Grant/award | 7,168 | — | — |
| 2026-06-24 | Beyman Yaakov |
Grant/award | 20,113 | — | — |
| 2026-06-24 | Beyman Mordechai Menachem |
Grant/award | 7,314 | — | — |
| 2026-06-24 | Beyman Ezra |
Grant/award | 151,575 | — | — |
| 2026-06-24 | Fruchtzweig Ben |
Grant/award | 7,168 | — | — |
| 2024-07-06 | Beyman Yaakov |
Shares withheld for tax | 1,498 | $3.10 | $4.6K |
Well-known investors holding EZRA (13F)
None of the 59 investors we track reported a position in their latest 13F.